4147.TWO
Price:
$84.5
Market Cap:
$23.08B
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infec...[Read more]
Industry
Biotechnology
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4147.TWO
According to TaiMed Biologics Inc.’s latest financial reports and current stock price. The company's current ROE is -5.17%. This represents a change of 297.28% compared to the average of -1.30% of the last 4 quarters.
The mean historical ROE of TaiMed Biologics Inc. over the last ten years is -9.65%. The current -5.17% ROE has changed -46.41% with respect to the historical average. Over the past ten years (40 quarters), 4147.TWO's ROE was at its highest in in the March 2018 quarter at 2.88%. The ROE was at its lowest in in the September 2015 quarter at -12.36%.
Average
-9.65%
Median
-8.76%
Minimum
-16.26%
Maximum
-5.02%
Discovering the peaks and valleys of TaiMed Biologics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 196.45%
Maximum Annual ROE = -5.02%
Minimum Annual Increase = -66.02%
Minimum Annual ROE = -16.26%
Year | ROE | Change |
---|---|---|
2024 | -5.02% | -33.91% |
2023 | -7.59% | -26.23% |
2022 | -10.29% | -36.72% |
2021 | -16.26% | 196.45% |
2020 | -5.49% | -66.02% |
2019 | -16.14% | 104.77% |
2018 | -7.88% | -35.49% |
2017 | -12.22% | 104.31% |
2016 | -5.98% | -37.86% |
2015 | -9.63% | -37.46% |
The current ROE of TaiMed Biologics Inc. (4147.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.63%
5-year avg
-8.93%
10-year avg
-9.65%
TaiMed Biologics Inc.’s ROE is greater than Medigen Biotechnology Corp. (-0.78%), greater than Sagittarius Life Science Corp (-12.29%), less than TTY Biopharm Company Limited (25.07%), less than PharmaEngine, Inc. (37.75%), greater than OBI Pharma, Inc. (-74.46%), less than Sunmax Biotechnology Co., Ltd. (56.08%), greater than Oneness Biotech Co., Ltd. (-9.79%), greater than EirGenix Inc. (-8.07%),
Company | ROE | Market cap |
---|---|---|
-0.78% | $4.23B | |
-12.29% | $3.27B | |
25.07% | $18.55B | |
37.75% | $10.87B | |
-74.46% | $8.56B | |
56.08% | $21.70B | |
-9.79% | $28.93B | |
-8.07% | $18.78B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiMed Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TaiMed Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TaiMed Biologics Inc.'s ROE?
How is the ROE calculated for TaiMed Biologics Inc. (4147.TWO)?
What is the highest ROE for TaiMed Biologics Inc. (4147.TWO)?
What is the 3-year average ROE for TaiMed Biologics Inc. (4147.TWO)?
What is the 5-year average ROE for TaiMed Biologics Inc. (4147.TWO)?
How does the current ROE for TaiMed Biologics Inc. (4147.TWO) compare to its historical average?